Invitro Toxicity Monitoring (Monitoring and Testing) News

Showcase

Thermo Fisher Scientific Completes Acquisition of Mesa Biotech

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has completed its previously announced acquisition of Mesa Biotech, Inc., a privately held point-of-care molecular diagnostic company. "Mesa Biotech is an important part of our strategy to expand the benefits of molecular diagnostics at the point of care, starting with COVID-19 testing," said Mark ...

Feb. 26, 2021

By Thermo Fisher Scientific, LIMS & Laboratory Software

FDA’s NCTR Highlights Its Nanotechnology-Related Activities in 2020

The January 29, 2021, issue of the U.S. Food and Drug Administration’s (FDA) NCTR Research Highlights includes an item highlighting the National Center for Toxicological Research’s (NCTR) nanotechnology-related activities in 2020. The activities include: Nanotechnology Standards: Two work items developed by the NCTR Nanotechnology Core Facility (Nanocore) staff became standards ...

Jan. 29, 2021

By Bergeson & Campbell, P.C.

Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones ...

Jan. 19, 2021

By Thermo Fisher Scientific, LIMS & Laboratory Software

BPC Joins European Research Institutes in a Major Greenhouse Gas Project

Dr. Jing Liu, Bioprocess Control CEO said: “Bioprocess Control acts as the sole industrial partner and will have a major role and responsibility in developing a new in-vitro laboratory test protocol, together with Lund University, using an automated batch fermentation analysis platform from Bioprocess Control to quantify methane and carbon dioxide produced in bulk slurry and at the ...

Dec. 10, 2020

By BPC Instruments AB (former Bioprocess Control)

The JRC releases new reference materials for the quality control of SARS-CoV-2 antibody tests

The JRC released two new reference materials, developed to function as quality assurance tools for the SARS-CoV-2 antibody tests used to verify if an individual has been infected by the COVID-19 virus. Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: "The correct functioning of antibody tests is particularly important in epidemiological investigations to ...

Dec. 7, 2020

By European Commission, Joint Research Centre (JRC)

Thermo Fisher Scientific Releases New CE-Marked COVID-19, Flu A/B, RSV Combo Kit

Thermo Fisher Scientific announces CE-marking of its TaqPath COVID-19, Flu A/B, RSV Combo Kit for the in vitro diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial virus (RSV) A/B infections. Using the new kit, laboratories can now can run a single test for SARS-CoV-2, influenza (flu) A/B, and RSV to detect and differentiate between diseases that share similar clinical symptoms, and ...

Dec. 7, 2020

By Thermo Fisher Scientific, LIMS & Laboratory Software

EFSA Calls for Grant Proposals on the Use of NAMs for the Hazard Assessment of Cellulose Nanofibers

On September 15, 2020, the European Food Safety Authority (EFSA) called for grant proposals on the use of new approach methodologies (NAM) for the hazard assessment of cellulose nanofibers. EFSA states that the use of cellulose at the nanoscale is increasing and requires an assessment. According to EFSA, the main concern is that the nanoscale characteristics (e.g., length/shape of the fibers) ...

Sep. 18, 2020

By Bergeson & Campbell, P.C.

Thermo Fisher Scientific Develops COVID-19 Antibody Assay Targeting Transplant Community

Thermo Fisher Scientific continues to expand its response to the COVID-19 pandemic, developing a new serological assay targeted towards transplant candidates and recipients that can detect antibodies directed against COVID-19 (SARS-CoV-2). The assay will be provided under the company's One Lambda brand representing leading in vitro diagnostic products for the transplant community. This novel ...

Aug. 10, 2020

By Thermo Fisher Scientific, LIMS & Laboratory Software

FDA Clears First Blood Test for Identifying a Novel Allergic Sensitization to Red Meat

ImmunoCAP Specific IgE alpha-Gal Allergen Component test has been cleared by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use. Test results can aid specialists and other healthcare providers as they diagnose a patient's sensitization to the alpha-Gal carbohydrate found in mammalian (red) meat and assess his or her risk for an anaphylactic reaction. According to the ...

Jul. 23, 2020

By Thermo Fisher Scientific, LIMS & Laboratory Software

Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia

Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing (NGS)–based diagnostics in Russia. The agreement enables First Genetics to market its F-Genetics NGS System and IVD assays ...

Jul. 13, 2020

By Thermo Fisher Scientific, LIMS & Laboratory Software

Thermo Fisher Scientific Launches New MAS Omni Infectious Disease Quality Controls

Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II. Serology testing for infectious diseases continues to be on the rise and newer instrument platforms are ...

Jul. 1, 2020

By Thermo Fisher Scientific, LIMS & Laboratory Software

Thermo Fisher Scientific and Daiichi Sankyo to Co-Develop Global Companion Diagnostic for Patients with Non-Small Cell Lung Cancer

Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will utilize Thermo Fisher's next-generation sequencing (NGS)-based Oncomine Dx Target Test. The CDx will be designed to identify non-small cell lung cancer (NSCLC) patients with human epidermal growth factor receptor 2 (HER2) mutations who may be ...

Jun. 23, 2020

By Thermo Fisher Scientific, LIMS & Laboratory Software

EUON Publishes Nanopinion on ECETOC’s NanoApp

On May 5, 2020, the European Union (EU) Observatory for Nanomaterials (EUON) published a Nanopinion entitled “NanoApp helps navigate legal obligations under REACH.” Olivier de Matos, Secretary General of the European Center for Ecotoxicology and Toxicology (ECETOC), describes the web-based app that was designed to help registrants follow the European Chemicals Agency’s (ECHA) ...

May 8, 2020

By Bergeson & Campbell, P.C.

New Blood Test Helps Clinicians Pinpoint A Potentially Life-Threatening Sensitization to Insect Stings

ImmunoCAP Specific IgE Stinging Insect Allergen Components have been cleared by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use. Results from these component tests can act as a diagnostic aid to help specialists and other healthcare providers discriminate between true sensitization and cross reactivity, identify culprit insect(s) in patients with inconclusive patient ...

Apr. 27, 2020

By Thermo Fisher Scientific, LIMS & Laboratory Software

Grifols and Shanghai RAAS close their strategic alliance in China

Grifols controls a 26.20% stake in Shanghai RAAS (economic and voting rights) in exchange for a non-majority share on behalf of Shanghai RAAS (45% economic rights and 40% voting rights) in Grifols’ subsidiary, Grifols Diagnostic Solutions (GDS) Over the past 35 years, Grifols has increasingly expanded its presence in China, which is currently the company’s third-largest sales ...

Mar. 27, 2020

By Grifols International, S.A.

Charles River Laboratories Updates Tumor Model Compendium

Charles River Laboratories International, Inc. (NYSE: CRL) today announced updates to its online Tumor Model Compendium. Charles River’s cancer model database provides access to a comprehensive collection of well-established tumor models for early-stage oncology research. This update adds 79 new patient-derived xenografts (PDX), 10 new cell line-derived xenografts (CDX), and 36 new cell ...

Dec. 4, 2019

By Charles River

Bioprocess Control Joins European Research Institutes in a Major Greenhouse Gas Research Project

Bioprocess Control will co-partner with Aarhus University (Denmark), Leibniz Institute for Agricultural Engineering and Bioeconomy (Germany), Wageningen Livestock Research (the Netherlands), RISE (Sweden) and Lund University (Sweden) on a project to develop a new method to estimate methane emissions from manure. This method will then be used to investigate farm-level greenhouse gas mitigation, ...

Oct. 25, 2019

By Royce Water technologies Pty Ltd

ERM-AD456/IFCC: A new certified material for quality control of alpha-amylase clinical measurements

The JRC released a new Certified Reference Material (CRM) ERM-AD456/IFCC containing the enzyme alpha-amylase which is a biomarker for disorders of the pancreas. This quality control material supports the standardisation of in vitro diagnostic tests and subsequently the comparability of results from routine clinical measurements. Alpha-amylase is a digestive enzyme that breaks down the ...

Oct. 8, 2019

By European Commission, Joint Research Centre (JRC)

New Blood Tests Help Assess Asthma Risk and Decide Pet Selection

AACC 2019 – New blood tests may help healthcare providers identify if patients are sensitized to up to 11 different molecular allergen component proteins found in dogs, cats, or horses. The assays analyze sensitivity to specific proteins found in the skin, fur and saliva of these animals. ImmunoCAP Allergen Components test for Furry Animal have been cleared by the U.S. Food & Drug ...

Aug. 6, 2019

By Thermo Fisher Scientific, LIMS & Laboratory Software

New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories

Thermo Fisher Scientific has expanded its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems now listed as Class I medical devices with the United States Food and Drug Administration (U.S. FDA). The portfolio enables clinical diagnostic laboratories to leverage a comprehensive platform for developing sensitive and reliable laboratory ...

Aug. 6, 2019

By Thermo Fisher Scientific, LIMS & Laboratory Software

Subscribe to our eBulletins